Equities research analysts at William Blair dropped their Q1 2025 earnings estimates for CeriBell in a research report issued ...
CeriBell (NASDAQ:CBLL) is based in the Silicon Valley, California and was founded in 2014 by Dr. Josef Parvizi, a Stanford neurologist. The company developed the CeriBell System, a portable AI ...
CeriBell Inc (CBLL) reports a 41% revenue increase and strategic expansions, despite facing increased operating expenses and supply chain tariffs. SUNNYVALE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE ...
2025 Financial Outlook Ceribell expects revenue for the full year 2025 to be in the range of $81 million to $85 million, representing growth of approximately 24% to 30% over the company’s prior year ...
NASDAQ CBLL opened at $22.69 on Monday. CeriBell has a one year low of $18.69 and a one year high of $32.75. The firm has a 50 day simple moving average of $22.93. CeriBell (NASDAQ:CBLL – Get ...
SUNNYVALE, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients ...
Reports Q4 revenue $18.53M, consensus $17.55M. “2024 was a transformative year for Ceribell (CBLL), as we advanced our mission to become the ...
Hello, and thank you for standing by. At this time, I would like to welcome you to the CeriBell Q4 2024 Earnings Call. All lines have been placed on mute to prevent any background noise.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback